Nearly a decade after spinning out its Chinese research hub to form Dizal Pharmaceutical, AstraZeneca is paying up to $1.5 billion to buy a piece of the pipeline, securing exclusive global rights for ...

In the second of a new series of interviews with top executives from leading healthcare and comms agencies, Fierce Pharma ...

Huyabio has scored a win in the largest oncology study it has undertaken in its 22 years, as its oral histone deacetylase ...

After speedrunning a series of major manufacturing milestones in the past year and a half, the “biotech floodgates” have ...

Insulet’s wearable insulin patch Omnipod may be able to seamlessly control insulin delivery for patients with diabetes, but ...

In an initiative to increase the efficiency of drug manufacturing in the United States, the FDA has proposed a streamlined ...

In what GSK says represents a potential way to transform treatment for patients with certain types of rectal cancer, the ...

Lupin Pharmaceuticals, the U.S. unit of India’s Lupin Limited, issued a voluntary recall of more than 2.5 million bottles of prednisolone acetate ophthalmic suspension after an undisclosed contaminant ...

Even as the effort has met with fierce pushback from drugmakers, trade groups and opposition parties in the country’s own ...

Sanofi has scored FDA approval for its subcutaneous version of Sarclisa, giving the multiple myeloma treatment a potential ...

Aiming to streamline the compensation process for people claiming harm from COVID-19 vaccines, Robert F. | Aiming to ...

AI has moved from emerging capability to executive mandate, yet many organizations are still struggling to translate ...